Tus kws kho mob
P5-18 New Medical Drug-Related PA Requirements for Yescarta and Kymriah
Hnub Tim pib siv tau lub khoos kas: Lub Ob Hlis Ntuj Tim 01, 2018
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 3251 - 3260 ntawm 3669
Tus kws kho mob
P32-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Kuvan
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 27, 2016
Tus kws kho mob
P42-16 Change in Medical Policy and Commercial Benefit Coverage of Cologuard Colorectal Cancer Screening Test
Hnub Tim pib siv tau lub khoos kas: Lub Yim Hlis Ntuj Tim 08, 2016
Tus kws kho mob
P1-17 Prior Authorization Requirement for Gender Dysphoria
Hnub Tim pib siv tau lub khoos kas: Lub Ib Hlis Ntuj 18, 2017
Tus kws kho mob
P57-17 Addition of Drugs to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 24, 2017
Tus kws kho mob
P39-17 Concurrent Review for Inpatient Hospital Services at Select Facilities
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 11, 2017
Tus kws kho mob
P62-16 EY Modifier for Platinum Blue Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 13, 2016
Tus kws kho mob
P48-16 Criteria Changes to Certain Services on the Prior Authorization List for MHCP Subscribers
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 26, 2016
Tus kws kho mob
P20-17 New Drug-Related Prior Authorization Criteria for QVAR (beclomethasone dipropionate HFA)
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 08, 2017
Tus kws kho mob
P37-17 Update to Attachment B: Definition of Outpatient Health Services Categories
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 22, 2017